tradingkey.logo
tradingkey.logo

Cibus Inc

CBUS
1.710USD
+0.170+11.04%
終値 12/19, 16:00ET15分遅れの株価
89.89M時価総額
損失額直近12ヶ月PER

Cibus Inc

1.710
+0.170+11.04%

詳細情報 Cibus Inc 企業名

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Cibus Incの企業情報

企業コードCBUS
会社名Cibus Inc
上場日Jul 20, 2017
最高経営責任者「CEO」Beetham (Peter Ronald)
従業員数157
証券種類Ordinary Share
決算期末Jul 20
本社所在地6455 Nancy Ridge Drive
都市SAN DIEGO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号92121
電話番号18584500008
ウェブサイトhttps://www.cibus.com/
企業コードCBUS
上場日Jul 20, 2017
最高経営責任者「CEO」Beetham (Peter Ronald)

Cibus Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%

収益内訳

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
933.00K
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Riggs (Rory B)
27.75%
Fidelity Management & Research Company LLC
13.93%
JPL Investments SA
3.18%
Vantage Consulting Group, Inc.
2.17%
The Vanguard Group, Inc.
1.83%
他の
51.14%
株主統計
株主統計
比率
Riggs (Rory B)
27.75%
Fidelity Management & Research Company LLC
13.93%
JPL Investments SA
3.18%
Vantage Consulting Group, Inc.
2.17%
The Vanguard Group, Inc.
1.83%
他の
51.14%
種類
株主統計
比率
Individual Investor
30.16%
Investment Advisor
17.15%
Corporation
3.25%
Investment Advisor/Hedge Fund
3.06%
Hedge Fund
0.89%
Family Office
0.21%
Research Firm
0.18%
Venture Capital
0.13%
Bank and Trust
0.10%
他の
44.87%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
155
11.44M
29.24%
--
2025Q3
160
11.44M
29.36%
-1.15M
2025Q2
160
12.59M
24.13%
+683.12K
2025Q1
154
11.90M
30.83%
+1.84M
2024Q4
150
9.30M
35.60%
+430.74K
2024Q3
137
8.87M
33.20%
+582.16K
2024Q2
125
8.28M
27.75%
+2.07M
2024Q1
106
6.21M
28.39%
+246.00K
2023Q4
96
5.70M
24.18%
+956.24K
2023Q3
100
4.74M
25.36%
+638.98K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Riggs (Rory B)
14.63M
27.84%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
7.17M
13.64%
+2.57M
+55.97%
Jun 30, 2025
JPL Investments SA
1.67M
3.19%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.18%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
856.15K
1.63%
-35.97K
-4.03%
Jun 30, 2025
Beetham (Peter Ronald)
382.44K
0.73%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.71%
+60.00K
+19.06%
Mar 24, 2025
BlackRock Institutional Trust Company, N.A.
456.21K
0.87%
-575.56K
-55.78%
Jun 30, 2025
Geode Capital Management, L.L.C.
257.74K
0.49%
-215.87K
-45.58%
Jun 30, 2025
Certior Financial Group, LLC
173.56K
0.33%
+27.21K
+18.59%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
比率0.01%
iShares Russell 2000 Value ETF
比率0%
Global X Russell 2000 ETF
比率0%
Proshares Ultra Russell 2000
比率0%
ProShares UltraPro Russell2000
比率0%
ProShares Hedge Replication ETF
比率0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
iShares Russell 2000 ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
日付
種類
比率
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1

よくある質問

Cibus Incの上位5名の株主は誰ですか?

Cibus Incの上位5名の株主は以下のとおりです。
Riggs (Rory B)は14.63M株を保有しており、これは全体の27.84%に相当します。
Fidelity Management & Research Company LLCは7.17M株を保有しており、これは全体の13.64%に相当します。
JPL Investments SAは1.67M株を保有しており、これは全体の3.19%に相当します。
Vantage Consulting Group, Inc.は1.14M株を保有しており、これは全体の2.18%に相当します。
The Vanguard Group, Inc.は856.15K株を保有しており、これは全体の1.63%に相当します。

Cibus Incの株主タイプ上位3種は何ですか?

Cibus Incの株主タイプ上位3種は、
Riggs (Rory B)
Fidelity Management & Research Company LLC
JPL Investments SA

Cibus Inc(CBUS)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Cibus Incの株式を保有している機関は155社あり、保有株式の総市場価値は約11.44Mで、全体の29.24%を占めています。2025Q3と比較して、機関の持ち株は-0.12%増加しています。

Cibus Incの最大の収益源は何ですか?

FY2025Q2において、--部門がCibus Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI